Top Morning News: Sony Corp (ADR) (NYSE:SNE), Actavis plc (NYSE:ACT), Raytheon Company (NYSE:RTN), Medtronic (NYSE:MDT), Covidien plc (NYSE:COV),

The Sony Corp. (ADR) (NYSE:SNE) sequel to 2012’s “21 Jump Street” collected $60 million at U.S. and Canadian theaters, beating DreamWorks Animation SKG Inc. (DWA)’s “How to Train Your Dragon 2” by $10 million, Rentrak Corp. said in a statement. Sony Corp (ADR) (NYSE:SNE) net profit margin is -1.60% and weekly performance is 0.75%. On last trading day company shares ended up $16.22. Analysts mean target price for the company is $21.51. Sony Corp (ADR) (NYSE:SNE) distance from 50-day simple moving average (SMA50) is -6.73%.

Actavis plc (NYSE:ACT) on 12 June announced that Forest Laboratories, Inc. (NYSE: RX) has received valid consents from holders of a majority in aggregate principal amount of each series of Forest’s securities listed in the table below to the elimination of Forest’s contractual registration rights obligations with respect to each series of FRX Notes. Actavis plc (NYSE:ACT) shares advanced 0.35% in last trading session and ended the day on $209.00. ACT gross Margin is 48.10% and its return on assets is -3.00%.Actavis plc (NYSE:ACT) quarterly performance is -2.57%.

Raytheon Company (NYSE:RTN) and Thales have signed a 27-month development and five-year production agreement in support of future improvements of Raytheon’s tube-launched, optically-tracked, wireless-guided (TOW) weapon system. Raytheon Company (NYSE:RTN) shares moved up 1.14% in last trading session and was closed at $96.59, while trading in range of $95.45 – $96.77. Raytheon Company (NYSE:RTN) year to date (YTD) performance is 7.16%.

U.S. medical device maker Medtronic Inc. (NYSE:MDT) said it agreed to buy Dublin-based Covidien Plc for $42.9 billion and shift its executive headquarters to Ireland in the latest move by U.S. Medtronic, Inc. (NYSE:MDT) ended the last trading day at $60.70. Company weekly volatility is calculated as 1.25% and price to cash ratio as 4.27.Medtronic, Inc. (NYSE:MDT) showed a negative weekly performance of -2.83%.

Medtronic, the world’s biggest medical devices maker by sales, will buy Ireland-based rival Covidien plc (NYSE:COV) in a $42.9 billion deal that will increase concerns about the rush of U.S. companies striking deals to cut their tax bills. Covidien plc (NYSE:COV) net profit margin is 15.50% and weekly performance is -2.15%. On last trading day company shares ended up $72.02. Analysts mean target price for the company is $79.25. Covidien plc (NYSE:COV) distance from 50-day simple moving average (SMA50) is 0.68%.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *